This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
Investors often find that companies with a history of increasing dividends perform better than those without. When a company’s management announces a dividend increase,...
Medtronic (NYSE:MDT) reported its Q4 fiscal year 2023 earnings on Thursday. The numbers looked strong at first glance, with both earnings and revenues topping...
Introduction As an investor in dividend growth companies, I always seek new investment opportunities in income-producing assets. I usually add to my existing positions...
Roche Holding AG (OTCQX:RHHBY, OTCPK:RHHVF, OTCQX:RHHBF) is a good long-term biotech to own. That’s because it already has received FDA approval for its multiple...